Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer.

Jedinak A, Loughlin KR, Moses MA.

Oncotarget. 2018 Aug 21;9(65):32534-32550. doi: 10.18632/oncotarget.25946. eCollection 2018 Aug 21. Review.

2.

Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).

Shao H, Li X, Moses MA, Gilbert LA, Kalyanaraman C, Young ZT, Chernova M, Journey SN, Weissman JS, Hann B, Jacobson MP, Neckers L, Gestwicki JE.

J Med Chem. 2018 Jul 26;61(14):6163-6177. doi: 10.1021/acs.jmedchem.8b00583. Epub 2018 Jul 13.

PMID:
29953808
3.

Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer.

Moses MA, Kim YS, Rivera-Marquez GM, Oshima N, Watson MJ, Beebe KE, Wells C, Lee S, Zuehlke AD, Shao H, Bingman WE 3rd, Kumar V, Malhotra SV, Weigel NL, Gestwicki JE, Trepel JB, Neckers LM.

Cancer Res. 2018 Jul 15;78(14):4022-4035. doi: 10.1158/0008-5472.CAN-17-3728. Epub 2018 May 15.

PMID:
29764864
4.

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells.

Huang J, Guo P, Moses MA.

J Vis Exp. 2018 Feb 16;(132). doi: 10.3791/57035.

PMID:
29553530
5.

Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed Nanomedicines.

Guo P, Wang B, Liu D, Yang J, Subramanyam K, McCarthy CR, Hebert J, Moses MA, Auguste DT.

Nano Lett. 2018 Apr 11;18(4):2254-2262. doi: 10.1021/acs.nanolett.7b04801. Epub 2018 Mar 12.

PMID:
29505261
6.

Nanomaterial Preparation by Extrusion through Nanoporous Membranes.

Guo P, Huang J, Zhao Y, Martin CR, Zare RN, Moses MA.

Small. 2018 May;14(18):e1703493. doi: 10.1002/smll.201703493. Epub 2018 Feb 22. Review.

PMID:
29468837
7.

Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client class-specific Hsp90 phosphorylation.

Bachman AB, Keramisanou D, Xu W, Beebe K, Moses MA, Vasantha Kumar MV, Gray G, Noor RE, van der Vaart A, Neckers L, Gelis I.

Nat Commun. 2018 Jan 17;9(1):265. doi: 10.1038/s41467-017-02711-w.

8.

Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib.

Gordon LB, Campbell SE, Massaro JM, D'Agostino RB Sr, Kleinman ME, Kieran MW, Moses MA.

Pediatr Res. 2018 May;83(5):982-992. doi: 10.1038/pr.2018.9. Epub 2018 Feb 28.

PMID:
29342131
9.

Nanoparticle elasticity directs tumor uptake.

Guo P, Liu D, Subramanyam K, Wang B, Yang J, Huang J, Auguste DT, Moses MA.

Nat Commun. 2018 Jan 9;9(1):130. doi: 10.1038/s41467-017-02588-9.

10.

Heat shock protein 90: its inhibition and function.

Zuehlke AD, Moses MA, Neckers L.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738). pii: 20160527. doi: 10.1098/rstb.2016.0527. Review.

PMID:
29203712
11.

Alpha band frequency differences between low-trait and high-trait anxious individuals.

Ward RT, Smith SL, Kraus BT, Allen AV, Moses MA, Simon-Dack SL.

Neuroreport. 2018 Jan 17;29(2):79-83. doi: 10.1097/WNR.0000000000000915.

PMID:
29189634
12.

Host non-inflammatory neutrophils mediate the engraftment of bioengineered vascular networks.

Lin RZ, Lee CN, Moreno-Luna R, Neumeyer J, Piekarski B, Zhou P, Moses MA, Sachdev M, Pu WT, Emani S, Melero-Martin JM.

Nat Biomed Eng. 2017;1. pii: 0081. doi: 10.1038/s41551-017-0081. Epub 2017 Jun 13.

13.

ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.

Roy R, Dagher A, Butterfield C, Moses MA.

Mol Cancer Res. 2017 Nov;15(11):1608-1622. doi: 10.1158/1541-7786.MCR-17-0188. Epub 2017 Aug 1.

PMID:
28765266
14.

Urinary kallikrein 10 predicts the incurability of gastric cancer.

Shimura T, Ebi M, Yamada T, Yamada T, Katano T, Nojiri Y, Iwasaki H, Nomura S, Hayashi N, Mori Y, Kataoka H, Moses MA, Joh T.

Oncotarget. 2017 Apr 25;8(17):29247-29257. doi: 10.18632/oncotarget.16453.

15.

A quantitative method for screening and identifying molecular targets for nanomedicine.

Guo P, Yang J, Bielenberg DR, Dillon D, Zurakowski D, Moses MA, Auguste DT.

J Control Release. 2017 Oct 10;263:57-67. doi: 10.1016/j.jconrel.2017.03.030. Epub 2017 Mar 22.

PMID:
28341549
16.

Characterization of dormant and active human cancer cells by quantitative phase imaging.

Guo P, Huang J, Moses MA.

Cytometry A. 2017 May;91(5):424-432. doi: 10.1002/cyto.a.23083. Epub 2017 Mar 17.

17.

Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

Dagher A, Curatolo A, Sachdev M, Stephens AJ, Mullins C, Landis JR, van Bokhoven A, El-Hayek A, Froehlich JW, Briscoe AC, Roy R, Yang J, Pontari MA, Zurakowski D, Lee RS, Moses MA; MAPP Research Network.

BJU Int. 2017 Jul;120(1):130-142. doi: 10.1111/bju.13832. Epub 2017 Apr 11.

18.

ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer.

Guo P, Yang J, Jia D, Moses MA, Auguste DT.

Theranostics. 2016 Jan 1;6(1):1-13. doi: 10.7150/thno.12167. eCollection 2016.

19.

Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases.

Yang J, Roy R, Jedinak A, Moses MA.

Cancer J. 2015 Jul-Aug;21(4):327-36. doi: 10.1097/PPO.0000000000000139. Review.

PMID:
26222086
20.

Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins.

Nakayama H, Huang L, Kelly RP, Oudenaarden CR, Dagher A, Hofmann NA, Moses MA, Bischoff J, Klagsbrun M.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):126-32. doi: 10.1016/j.bbrc.2015.06.087. Epub 2015 Jun 15.

PMID:
26086095

Supplemental Content

Loading ...
Support Center